Tired of Reading? Please listen to the blog
WHO states that cholesterol causes 2.6 million deaths globally. Cardiologists prefer to use Statins to treat high blood cholesterol conditions which is the leading cause of CVDs. Previous studies on the effects of the drug conducted in 2011 highlighted the benefits of using the drug to treat cholesterol levels. New trials and reviews are required to analyze the efficacy of the drug. India is facing a shortage of 88,000 qualified cardiologists and with increasing demand fellowship in non-invasive cardiology program from TAU has gained popularity. It’s a two-year program offered in partnership with UCN.
Are you a cardiologist or planning to become one? Here are a few key facts that every invasive, interventional, or even non-invasive cardiologist should know about the prevalence of cardiovascular diseases (CVDs).
High blood cholesterol is one of the highest risk contributing factors to CVDs in humans. According to the World Health Organization (WHO), CVD is the number one cause of death globally. More people die yearly from CVDs than any other reason.
Reducing cases of high blood cholesterol, which is a crucial risk factor contributing to CVD in people with and without a history of CVD, this factor is the primary goal of pharmacotherapy.
WHO reports that overall high blood cholesterol is estimated to cause 2.6 million deaths annually on a global scale. CVDs are also one of the significant contributors to deaths among the Indian population. In India, the death rate from CVDs was three times higher than that of cancer.
A class of drugs known as Statins is the first choice of cardiologists against high blood cholesterol conditions. Previous studies of the effects of the drug have highlighted their benefits in people with CVD. However, the case for primary prevention was unknown. The last reported review of this drug regarding its preventable function was in 2011, and in light of new data recently, an update of this review is now feasible.
This article explores the feasibility of utilizing stains as a viable preventative measure against high blood cholesterol and supports said findings with the data they have accumulated by trails and follow-ups with test subjects.
It is also important to note that the global and Indian medical industry faces a severe shortage of skilled cardiologists. A report suggested that India has a lack of specialist doctors. For instance, there are only 4,000 cardiologists in India, wherein practice a minimum of 88,000 personnel are required.
Owing to this demand for cardiologists, fellowship in cardiology in India has risen in popularity among doctors in recent times. These latest findings may be critical in preventing high blood cholesterol and is a piece of vital information for Cardiologists.
These days there are many options for a PG course after MBBS. One can opt for a non-invasive cardiology course after MBBS to become a non-invasive cardiologist if they wish for a quicker route. Unlike a traditional PG course after MBBS degree, a long and arduous process, a cardiology fellowship course after MBBS can be pursued in just two years with Texila American University, offering in association with the University of Central Nicaragua.
Choose a non-invasive cardiology course at Texila American University and become a cardiologist in India!